GMDAQ (Gamida Cell) Cash, Cash Equivalents, Marketable Secu
What is Gamida Cell Cash, Cash Equivalents, Marketable Securities? Gamida Cell‘s quarterly cash, cash equivalents, marketable securities declined from Sep. 2023 ($60.43 Mil) to Dec. 2023 ($46.55 Mil) but then stayed the same from Dec. 2023 ($46.55 Mil) to Mar. 2024 ($24.78 Mil). Gamida Cell‘s annual cash, cash equivalents, marketable securities declined from Dec. 2021